GSK Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:GS70 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
20 Dec 23	Buy€24,263	Vishal Sikka	Individual	727	€33.37
20 Dec 23	Buy€7,609	Hal Barron	Individual	228	€33.37
20 Dec 23	Buy€7,576	Harry Dietz	Individual	227	€33.37
20 Dec 23	Buy€7,576	Anne Beal	Individual	227	€33.37
20 Dec 23	Buy€58,639	Charles Bancroft	Individual	1,757	€33.37
20 Dec 23	Buy€7,609	Elizabeth Anderson	Individual	228	€33.37
20 Dec 23	Buy€7,576	Jesse Goodman	Individual	227	€33.37
20 Sep 23	Buy€28,024	Vishal Sikka	Individual	790	€35.47
20 Sep 23	Buy€7,769	Hal Barron	Individual	219	€35.47
20 Sep 23	Buy€7,804	Harry Dietz	Individual	220	€35.47
20 Sep 23	Buy€59,987	Charles Bancroft	Individual	1,691	€35.47
20 Sep 23	Buy€7,769	Elizabeth Anderson	Individual	219	€35.47
20 Sep 23	Buy€7,804	Jesse Goodman	Individual	220	€35.47
20 Jun 23	Buy€27,521	Vishal Sikka	Individual	864	€31.85
20 Jun 23	Buy€7,645	Hal Barron	Individual	240	€31.85
20 Jun 23	Buy€7,645	Harry Dietz	Individual	240	€31.85
20 Jun 23	Buy€7,645	Anne Beal	Individual	240	€31.85
20 Jun 23	Buy€52,431	Charles Bancroft	Individual	1,646	€31.85
20 Jun 23	Buy€7,645	Elizabeth Anderson	Individual	240	€31.85
20 Jun 23	Buy€7,645	Jesse Goodman	Individual	240	€31.85

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GS70?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	2,876,139	0.0704%
Individual Insiders	4,580,779	0.112%
State or Government	8,424,577	0.206%
Private Companies	48,858,117	1.2%
Employee Share Scheme	82,340,591	2.02%
General Public	530,439,991	13%
Institutions	3,408,542,555	83.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 49.04% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.23%	Dodge & Cox	377,080,692	€7.4b	-0.58%	3.5%
8.17%	BlackRock, Inc.	333,814,330	€6.5b	-0.21%	0.12%
4.64%	The Vanguard Group, Inc.	189,450,566	€3.7b	2.2%	0.07%
2.35%	State Street Global Advisors, Inc.	96,070,919	€1.9b	1.91%	0.08%
2.21%	Norges Bank Investment Management	90,371,357	€1.8b	-4.83%	0.16%
2.08%	Legal & General Investment Management Limited	84,809,119	€1.7b	2.39%	0.36%
2.02%	GlaxoSmithKline Employee Trust	82,340,591	€1.6b	31.4%	no data
1.64%	Schroder Investment Management Limited	67,162,712	€1.3b	0.29%	0.91%
1.53%	UBS Asset Management AG	62,322,156	€1.2b	4.39%	0.18%
1.36%	Silchester International Investors LLP	55,504,791	€1.1b	0.15%	4.49%
1.32%	FMR LLC	53,986,854	€1.1b	10.4%	0.07%
1.2%	Mondrian Investment Partners Limited	49,224,258	€963.1m	0.16%	6.54%
1.19%	HSBC Global Asset Management (UK) Limited	48,492,384	€948.8m	11%	0.52%
1.18%	GlaxoSmithKline plc, Shareview Client	48,094,521	€941.0m	-0.9%	no data
1.11%	Columbia Management Investment Advisers, LLC	45,417,911	€888.6m	5.21%	0.23%
1.04%	Royal Bank of Canada Trust Company (Bahamas) Limited, Asset Management Arm	42,407,746	€829.7m	71%	22.93%
0.9%	Aviva Investors Global Services Ltd.	36,968,007	€723.3m	1.13%	1.1%
0.83%	Wellington Management Group LLP	33,808,189	€661.5m	-2.87%	0.11%
0.82%	Fisher Asset Management, LLC	33,317,889	€651.9m	1.06%	0.33%
0.8%	Franklin Resources, Inc.	32,752,139	€640.8m	4.69%	0.25%
0.75%	JP Morgan Asset Management	30,695,488	€600.6m	3.51%	0.08%
0.74%	Causeway Capital Management LLC	30,220,101	€591.3m	9.95%	2.7%
0.66%	Jupiter Fund Management Plc	26,807,896	€524.5m	-1.48%	1.44%
0.65%	Amundi Asset Management SAS	26,651,354	€521.5m	30.4%	0.12%
0.64%	T. Rowe Price Group, Inc.	26,192,730	€512.5m	1.11%	0.05%